Dr. Michael S. Weinstein, MD

Dr. Weinstein practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Weinstein's NPI, 1427165067, was assigned on August 23, 2006. Dr. Weinstein holds California license G88894.

Dr. Weinstein's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Weinstein's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. Dr. Weinstein is also affiliated with Providence Santa Rosa Memorial Hospital. The medical group on file is St. Jude Heritage Medical Group. Dmand AI also links Dr. Weinstein to 4 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Weinstein practices, 6 sites in all. Vendor and product names are available with a free account.

Physical medicine and rehabilitation is Dr. Weinstein's primary specialty in the NPI Registry, under taxonomy code 208100000X. Dmand AI has Dr. Weinstein's licenses on file in 2 states: California and Washington.

CMS data shows 686 Medicare services from Dr. Weinstein across 4 procedure codes in 2024, for 94 Medicare patients. Medicare paid $42,092 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 94 Medicare patients who saw Dr. Weinstein in 2024. The largest group is 75 to 84, with 42 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Weinstein's median patient age at 75, with 48% women.

In 2024, Dr. Weinstein wrote 22 Medicare Part D claims. 100% of them were for generic drugs. CMS names the drug for 19 of them, across 1 drug with 11 or more claims each, at $114 in total drug cost. In 2019, CMS named 26 claims across 2 drugs.

Dr. Weinstein accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Dr. Weinstein from 1 drug or device company in 2023. Food and beverage make up the largest share, 100% of the total. Neurocrine BioSciences, Inc. paid the most, $88.